文献速递传染病防控与疫情报告卫生政策与健康促进

从尼日利亚返回的旅行者中的猴痘——德克萨斯州达拉斯,2021年7月

Monkeypox in a Traveler Returning from Nigeria - Dallas, Texas, July 2021.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2022-04-08

2021年7月,一名从尼日利亚拉各斯前往美国德克萨斯州达拉斯的男子被诊断为猴痘,成为第七例在非洲以外国家确诊猴痘的旅行者。194名监测接触者中144人(74%)为航班接触者。患者接受tecovirimat治疗,家庭需大规模消毒。全基因组测序显示病毒与已知在尼日利亚流行的猴痘病毒株一致,但未确定具体感染源。

要点

  • 从尼日利亚返回的旅行者中发生猴痘输入病例,需警惕旅行相关猴痘监测。
  • 194名监测接触者中144人(74%)为航班接触者,未采用ACAM2000疫苗暴露后预防。
  • 全基因组测序显示病毒与尼日利亚流行株一致,但感染源未明确。

核心结论

  • 该病例为第七例在非洲以外国家确诊猴痘的尼日利亚旅行者,未发现流行病学关联病例,未确定具体感染源。

研究设计与样本

  • 病例报告:一名2021年7月从尼日利亚拉各斯旅行至美国德克萨斯州达拉斯的男子。

主要发现

  • 194名监测接触者中144人(74%)为航班接触者。
  • 患者接受tecovirimat治疗,其家庭需大规模消毒。
  • 全基因组测序显示病毒与已知在尼日利亚流行的猴痘病毒株一致,但未确定患者感染的具体来源。
  • 尼日利亚未报告流行病学关联病例;无接触者接受ACAM2000疫苗暴露后预防。

临床怎么用

  • 患者接受tecovirimat治疗,其家庭需大规模消毒。
  • 无接触者接受ACAM2000疫苗暴露后预防。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Monkeypox is a rare, sometimes life-threatening zoonotic infection that occurs in west and central Africa. It is caused by Monkeypox virus, an orthopoxvirus similar to Variola virus (the causative agent of smallpox) and Vaccinia virus (the live virus component of orthopoxvirus vaccines) and can spread to humans. After 39 years without detection of human disease in Nigeria, an outbreak involving 118 confirmed cases was identified during 2017-2018 (1); sporadic cases continue to occur. During September 2018-May 2021, six unrelated persons traveling from Nigeria received diagnoses of monkeypox in non-African countries: four in the United Kingdom and one each in Israel and Singapore. In July 2021, a man who traveled from Lagos, Nigeria, to Dallas, Texas, became the seventh traveler to a non-African country with diagnosed monkeypox. Among 194 monitored contacts, 144 (74%) were flight contacts. The patient received tecovirimat, an antiviral for treatment of orthopoxvirus infections, and his home required large-scale decontamination. Whole genome sequencing showed that the virus was consistent with a strain of Monkeypox virus known to circulate in Nigeria, but the specific source of the patient's infection was not identified. No epidemiologically linked cases were reported in Nigeria; no contact received postexposure prophylaxis (PEP) with the orthopoxvirus vaccine ACAM2000.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Rao AK, Schulte J, Chen TH, et al. Monkeypox in a Traveler Returning from Nigeria - Dallas, Texas, July 2021. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35389974. doi:10.15585/mmwr.mm7114a1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。